Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT06801769
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 and 80 years
* HbA1c \<10% or fasting glucose \<250 mg/dL
* Ability to understand and provide informed consent regarding the procedures, data collection, and analysis.
Exclusion Criteria:
* Age \<18 years or \>80 years
* History of diabetes treated with insulin
* HbA1c \>10% or fasting glucose \>250 mg/dL
* Pancreatic diseases (solid tumors/secretory NETs/cystic fibrosis; non-secretory NETs and IPMN may be included)
* Previous pancreatic surgery
* Moderate anemia (Hb \<10 mg/dL)
* Severe liver failure (Child-Pugh C)
* Non-metabolic causes of NAPLD (e.g., corticosteroid therapy, antiretrovirals, gemcitabine, octreotide, history of hemochromatosis, malnutrition, HBV/HIV infections)
* Alcohol abuse (\>30 g/day of ethanol)
* Pregnancy and breastfeeding
* Inability to adequately understand informed consent and study procedures
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06801769
Study Brief:
Protocol Section:
NCT06801769